259
Views
0
CrossRef citations to date
0
Altmetric
Invited Reviews

Advances and challenges in the measurement of 1,25-dihydroxyvitamin D: a comprehensive review

ORCID Icon, ORCID Icon & ORCID Icon
Pages 535-548 | Received 24 Feb 2023, Accepted 08 May 2023, Published online: 05 Jun 2023

References

  • Hollis BW. Assessment and interpretation of circulating 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin North Am. 2010;39(2):271–286.
  • Hollis BW. Measuring 25-hydroxyvitamin D in a clinical environment: challenges and needs. Am J Clin Nutr. 2008;88(2):507S–510S.
  • Hollis BW. Assessment of vitamin D status and definition of a normal circulating range of 25-hydroxyvitamin D. Curr Opin Endocrinol Diabetes Obes. 2008;15(6):489–494.
  • Tuckey RC, Cheng CYS, Slominski AT. The serum vitamin D metabolome: what we know and what is still to discover. J Steroid Biochem Mol Biol. 2019;186:4–21.
  • Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19(2):73–78.
  • Couchman L, Moniz CF. Analytical considerations for the biochemical assessment of vitamin D status. Ther Adv Musculoskelet Dis. 2017;9(4):97–104.
  • Farrell CJ, Herrmann M. Determination of vitamin D and its metabolites. Best Pract Res Clin Endocrinol Metab. 2013;27(5):675–688.
  • Zerwekh JE. The measurement of vitamin D: analytical aspects. Ann Clin Biochem. 2004;41(Pt 4):272–281.
  • Bikle DD. Vitamin D assays. Front Horm Res. 2018;50:14–30.
  • McCollum EV, Simmonds N, Becker JE, et al. An experimental demonstration of the existence of a vitamin which promotes calcium deposition. J Biol Chem. 1922;53(2):293–312.
  • McCollum EV. The paths to the discovery of vitamins a and D. J Nutr. 1967;91(2):11–16.
  • Jones G, Vitamin D. The Cambridge world history of food. Part IVA4. (Kiple KF, Ornelas KC, editors). Cambridge: University of Cambridge Press; 2000. pp. 763–768.
  • Jones G. 100 Years of vitamin D: historical aspects of vitamin D. Endocr Connect. 2022;11(4):e210594.
  • Neville PF, DeLuca HF. The synthesis of [1,2-3H] vitamin D3 and the tissue localization of a 0.25-mu-g (10 IU) dose per rat. Biochemistry. 1966;5(7):2201–2207.
  • Blunt JW, DeLuca HF, Schnoes HK. 25-hydroxycholecalciferol. A biologically active metabolite of vitamin D3. Biochemistry. 1968;7(10):3317–3322.
  • Lawson DE, Wilson PW, Kodicek E. Metabolism of vitamin D. A new cholecalciferol metabolite, involving loss of hydrogen at C-1, in chick intestinal nuclei. Biochem J. 1969;115(2):269–277.
  • Fraser DR, Kodicek E. Unique biosynthesis by kidney of a biological active vitamin D metabolite. Nature. 1970;228(5273):764–766.
  • Norman AW, Myrtle JF, Midgett RJ, et al. 1,25-dihydroxycholecalciferol: identification of the proposed active form of vitamin D3 in the intestine. Science. 1971;173(3991):51–54.
  • Lawson DE, Fraser DR, Kodicek E, et al. Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature. 1971;230(5291):228–230.
  • Holick MF, Schnoes HK, DeLuca HF, et al. Isolation and identification of 1,25-dihydroxycholecalciferol. A metabolite of vitamin D active in intestine. Biochemistry. 1971;10(14):2799–2804.
  • Brumbaugh PF, Haussler MR. Specific binding of 1alpha,25-dihydroxycholecalciferol to nuclear components of chick intestine. J Biol Chem. 1975;250(4):1588–1594.
  • Bouillon R, Vitamin D. From photosynthesis, metabolism, and action to clinical applications. In: DeGroot LJ, Jameson JL, editors. Endocrinology. Philadelphia: WB Saunders; 2001. p. 1009–1028.
  • Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353–373.
  • Makris K, Bhattoa HP, Cavalier E, et al. Recommendations on the measurement and the clinical use of vitamin D metabolites and vitamin D binding protein - A position paper from the IFCC committee on bone metabolism. Clin Chim Acta. 2021;517:171–197.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, Endocrine Society, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. Jul
  • Levine MA. Diagnosis and management of vitamin D dependent rickets. Front Pediatr. 2020;8:315.
  • Brumbaugh PF, Haussler DH, Bursac KM, et al. Filter assay for 1alpha, 25-dihydroxyvitamin D3. Utilization of the hormone’s target tissue chromatin receptor. Biochemistry. 1974;13(20):4091–4097. Sep 24
  • Brumbaugh PF, Haussler DH, Bressler R, et al. Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3. Science. 1974;183(4129):1089–1091.
  • Hughes MR, Baylink DJ, Jones PG, et al. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3. J Clin Invest. 1976;58(1):61–70.
  • Eisman JA, Hamstra AJ, Kream BE, et al. A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. Arch Biochem Biophys. 1976;176(1):235–243.
  • Imawari M, Kozawa K, Yoshida T, et al. A simple and sensitive assay for 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human serum. Clin Chim Acta. 1982;124(1):63–73.
  • Reinhardt TA, Horst RL, Orf JW, et al. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab. 1984;58(1):91–98. Jan
  • Hollis BW. Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem. 1986;32(11):2060–2063.
  • Hollis BW. Phase switching SPE for faster 1,25-dihydroxyvitamin D analysis. Clin Chem. 2008;54(2):446–447.
  • Reinhardt TA, Horst RL, Littledike ET, et al. 1,25-Dihydroxyvitamin D3 receptor in bovine thymus gland. Biochem Biophys Res Commun. 1982;106(3):1012–1018.
  • Chen TC, Turner AK, Holick MF. A method for the determination of the circulating concentration of 1,25-dihydroxyvitamin D. J Nutr Biochem. 1990;1(6):320–327.
  • Hartwell D, Christiansen C. Comparisons between two receptor assays for 1,25-dihydroxyvitamin D. Scand J Clin Lab Invest. 1988;48(2):109–114.
  • Poon PM, Mak YT, Pang CP. Gas chromatographic-mass fragmentographic determination of serum 1 alpha,25 dihydroxyvitamin D3. Clin Biochem. 1993;26(6):461–469.
  • Oftebro H, Falch JA, Holmberg I, et al. Validation of a radioreceptor assay for 1,25-dihydroxyvitamin D using selected ion monitoring GC-MS. Clin Chim Acta. 1988;176(2):157–168. Aug 31
  • Coldwell RD, Porteous CE, Trafford DJ, et al. Gas chromatography-mass spectrometry and the measurement of vitamin D metabolites in human serum or plasma. Steroids. 1987;49(1-3):155–196. Jan-Mar
  • Lin L, Meltzer NM, Honigberg IL. Normal phase HPLC with EC detection: 1,25-Dihydroxy vitamin D3 and 25-hydroxy-16-ene-23-yne vitamin D3. J Liq Chromatog. 1993;16(14):3093–3100.
  • Kobayashi N, Mano H, Imazu T, et al. Tandem immunoaffinity chromatography for plasma 1α,25-dihydroxyvitamin D3 utilizing two antibodies having different specificities: a novel and powerful pretreatment tool for 1α,25-dihydroxyvitamin D3 radioreceptor assays. J Steroid Biochem Mol Biol. 1995;54(5-6):217–226.
  • Clemens TL, Hendy GN, Graham RF, et al. A radioimmunoassay for 1,25-dihydroxycholecalciferol. Clin Sci Mol Med. 1978;54(3):329–332.
  • Scharla S, Reichel H. A sensitive radioimmunoassay for 1,25-dihydroxyvitamin d3 (calcitriol) after high-performance liquid chromatography of plasma or serum extracts. In: Schmidt-Gayk H, Armbruster FP, Bouillon R, editors. Calcium regulating hormones, vitamin D metabolites, and cyclic AMP assays and their clinical application. Berlin, Heidelberg: Springer; 1990. pp. 300–317.
  • Peacock M, Taylor GA, Brown W. Plasma 1,25(OH)2D vitamin D measured by radioimmunoassay and cytosol radioreceptor assay in normal subjects and patients with primary hyperparathyroidism and renal failure. Clin Chim Acta. 1980;101(1):93–101.
  • Armbruster FP, Reichel H, Vogel G, et al. Development of a double antibody radioimmunoassay for quantitation of 1 alpha,25-dihydroxyvitamin D. Clin Chim Acta. 1990;189(2):97–110.
  • Mawer EB, Berry JL, Cundall JP, et al. A sensitive radioimmunoassay using a monoclonal antibody that is equipotent for ercalcitriol and calcitriol (1,25-dihydroxy vitamin D2 and D3). Clin Chim Acta. 1990;190(3):199–209.
  • De Leenheer AP, Bauwens RM. Radioimmunoassay for 1,25-dihydroxyvitamin D in serum or plasma. Clin Chem. volume1 January 1985;31Issue(1):142–146.
  • De Leenheer AP, Bauwens RM. Comparison of a cytosol radioreceptor assay with a radioimmunoassay for 1,25-dihydroxyvitamin D in serum or plasma. Clin Chim Acta. 1985;152(1-2):143–154.
  • Hollis BW, Kamerud JQ, Kurkowski A, et al. Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clin Chem. 1996;42(4):586–592.
  • Fraser WD, Durham BH, Berry JL, et al. Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. Ann Clin Biochem. 1997;34(6):632–637.
  • FDA. 2002. DiaSorin 1,25-Dihydroxyvitamin D 125I RIA. 510(k) No. K014030. https://www.accessdata.fda.gov/cdrh_docs/pdf/K014030.pdf
  • FDA. 2004. Immunodiagnostic Systems Gamma-B 1,25-Dihydroxy Vitamin D RIA. 510(k) No. k042519. https://www.accessdata.fda.gov/cdrh_docs/reviews/K042519.pdf
  • FDA. 2005. IDS 1,25-Dihydroxy Vitamin D EIA. 510(k) No. k051110. https://www.accessdata.fda.gov/cdrh_docs/reviews/K051110.pdf
  • Seiden-Long I, Vieth R. Evaluation of a 1,25-dihydroxyvitamin D enzyme immunoassay. Clin Chem. 2007;53(6):1104–1108.
  • Kimball SM, Vieth R. A comparison of automated methods for the quantitation of serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D. Clin Biochem. 2007;40(16-17):1305–1310.
  • FDA. 2014. LIAISON® XL 1,25 Dihydroxyvitamin D. 510(k) No. K141463. https://www.accessdata.fda.gov/cdrh_docs/pdf14/K141463.pdf
  • FDA. 2013. IDS iSYS 1,25 Dihydroxyvitamin D. 510(k) No. K123253. https://www.accessdata.fda.gov/cdrh_docs/pdf12/K123253.pdf
  • Kissmeyer AM, Sonne K. Sensitive analysis of 1α,25-dihydroxyvitamin D3 in biological fluids by liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2001;935(1-2):93–103.
  • Aronov PA, Hall LM, Dettmer K, et al. Metabolic profiling of major vitamin D metabolites using Diels-Alder derivatization and ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 2008;391(5):1917–1930.
  • Duan X, Weinstock-Guttman B, Wang H, et al. Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass spectrometry. Anal Chem. 2010;82(6):2488–2497.
  • Ding S, Schoenmakers I, Jones K, et al. Quantitative determination of vitamin D metabolites in plasma using UHPLC-MS/MS. Anal Bioanal Chem. 2010;398(2):779–789.
  • Casetta B, Jans I, Billen J, et al. Development of a method for the quantification of 1α,25(OH)2-vitamin D3 in serum by liquid chromatography tandem mass spectrometry without derivatization. Eur J Mass Spectrom. 2010;16(1):81–89.
  • Yuan C, Kosewick J, He X, et al. Sensitive measurement of serum 1α,25-dihydroxyvitamin D by liquid chromatography/tandem mass spectrometry after removing interference with immunoaffinity extraction. Rapid Commun Mass Spectrom. 2011;25(9):1241–1249.
  • Strathmann FG, Laha TJ, Hoofnagle AN. Quantification of 1α,25-dihydroxy vitamin D by immunoextraction and liquid chromatography - Tandem mass spectrometry. Clin Chem. 2011;57(9):1279–1285.
  • Wang Z, Senn T, Kalhorn T, et al. Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry. Anal Biochem. 2011;418(1):126–133.
  • Laha TJ, Strathmann FG, Wang Z, et al. Characterizing antibody cross-reactivity for immunoaffinity purification of analytes prior to multiplexed liquid chromatography-tandem mass spectrometry. Clin Chem. 2012;58(12):1711–1716.
  • Hedman CJ, Wiebe DA, Dey S, et al. Development of a sensitive LC/MS/MS method for vitamin D metabolites: 1,25 dihydroxyvitamin D2&3 measurement using a novel derivatization agent. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;953-954(1):62–67.
  • Chan N, Kaleta EJ. Quantitation of 1α,25-dihydroxyvitamin D by LC-MS/MS using solid-phase extraction and fixed-charge derivitization in comparison to immunoextraction. Clin Chem Lab Med. 2015;53(9):1399–1407.
  • Fang H, Yu S, Cheng Q, et al. Determination of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in human serum using liquid chromatography with tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2016;1027:19–26.
  • Dirks NF, Martens F, Vanderschueren D, et al. Determination of human reference values for serum total 1,25-dihydroxyvitamin D using an extensively validated 2D ID-UPLC-MS/MS method. J Steroid Biochem Mol Biol. 2016;164:127–133.
  • Wan D, Yang J, Barnych B, et al. A new sensitive LC/MS/MS analysis of vitamin D metabolites using a click derivatization reagent, 2-nitrosopyridine. J Lipid Res. 2017;58(4):798–808.
  • Jin Z, Bertholf RL, Yi X. Overcome isomer interference in 1α,25-dihydroxyvitamin D quantitation by liquid chromatography-tandem mass spectrometry. J Appl Lab Med. 2022;7(3):737–746.
  • Xu S, Ni R, Lv L, et al. Simultaneous determination of vitamin D metabolites 25(OH)D3 and 1α,25(OH)2D3 in human plasma using liquid chromatography tandem mass spectrometry. J Mass Spectrom Adv Clin Lab. 2022;24(April):65–79.
  • Higashi T, Awada D, Shimada K. Simultaneous determination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 in human plasma by liquid chromatography-tandem mass spectrometry employing derivatization with a cookson-type reagent. Biol Pharm Bull. 2001;24(7):738–743.
  • Higashi T, Yamauchi A, Shimada K. Application of 4-(4-nitrophenyl)-1,2,4-triazoline-3,5-dione to analysis of 25-hydroxyvitamin D3 in human plasma by liquid chromatography/electron capture atmospheric pressure chemical ionization-mass spectrometry. Anal Sci. 2003;19(6):941–943.
  • Murao N, Ishigai M, Sekiguchi N, et al. Ferrocene-based Diels-Alder derivatization for the determination of 1alpha-hydroxyvitamin D3 in rat plasma by high-performance liquid chromatography-electrospray tandem mass spectrometry. Anal Biochem. 2005;346(1):158–166.
  • Higashi T, Homma S, Iwata H, et al. Characterization of urinary metabolites of vitamin D(3) in man under physiological conditions using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2002;29(5):947–955.
  • Alexandridou A, Schorr P, Stokes CS, et al. Analysis of vitamin D metabolic markers by mass spectrometry: recent progress regarding the "gold standard" method and integration into clinical practice. Mass Spectrom Rev. 2021. Online ahead of print.
  • Kamao M, Tatematsu S, Hatakeyama S, et al. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-Hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1α or C-24 hydroxylation. J Biol Chem. 2004;279(16):15897–15907.
  • Wang Z, Lin YS, Zheng XE, et al. An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol. 2012;81(4):498–509.
  • Xue Y, He X, Li HD, et al. Simultaneous quantification of 25-hydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in rats shows strong correlations between serum and brain tissue levels. Int J Endocrinol. 2015;2015:296531.
  • Higashi T, Awada D, Shimada K. Determination of 24,25-dihydroxyvitamin D(3) in human plasma using liquid chromatography-mass spectrometry after derivatization with a cookson-type reagent. Biomed Chromatogr. 2001;15(2):133–140.
  • Fu X, Dolnikowski GG, Patterson WB, et al. Determination of vitamin D and its metabolites in human brain using an ultra-pressure LC–tandem mass spectra method. Curr Dev Nutr. 2019;3(7):nzz074.
  • Qaw F, Calverley MJ, Schroeder NJ, et al. In vivo metabolism of the vitamin D analog, dihydrotachysterol. Evidence for formation of 1 alpha,25- and 1 beta,25-dihydroxy-dihydrotachysterol metabolites and studies of their biological activity. J Biol Chem. 1993;268(1):282–292.
  • Norman AW, Bouillon R, Farach-Carson MC, et al. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. J Biol Chem. 1993;268(27):20022–20030.
  • Pauwels S, Jans I, Billen J, et al. 1β,25-Dihydroxyvitamin D3: a new vitamin D metabolite in human serum. J Steroid Biochem Mol Biol. 2017;173:341–348.
  • Binkley N, Sempos CT, Vitamin D Standardization Program (VDSP) Standardizing vitamin D assays: the way forward. J Bone Miner Res. 2014;29(8):1709–1714.
  • Carter GD, Berry J, Durazo-Arvizu R, et al. Quality assessment of vitamin D metabolite assays used by clinical and research laboratories. J Steroid Biochem Mol Biol. 2017;173:100–104.
  • Camara JE, Wise SA, Hoofnagle AN, et al. Assessment of serum total 25-hydroxyvitamin D assay commutability of standard reference materials and college of American pathologists Accuracy-Based vitamin D (ABVD) scheme and vitamin D external quality assessment scheme (DEQAS) materials: vitamin D standardization program (VDSP) commutability study 2. Anal Bioanal Chem. 2021;413(20):5067–5084.
  • El-Khoury JM, Reineks EZ, Wang S. Progress of liquid chromatography-mass spectrometry in measurement of vitamin D metabolites and analogues. Clin Biochem. 2011;44(1):66–76.
  • Durazo-Arvizu RA, Ahmed F, Berry J, et al. Estimating uncertainty of target values for DEQAS serum materials. J Steroid Biochem Mol Biol. 2019;188:90–94.
  • Carter GD, Berry J, Durazo-Arvizu R, et al. Hydroxyvitamin D assays: an historical perspective from DEQAS. J Steroid Biochem Mol Biol. 2018;177:30–35.
  • Valcour A, Zierold C, Podgorski AL, et al. A novel, fully-automated, chemiluminescent assay for the detection of 1,25-dihydroxyvitamin D in biological samples. J Steroid Biochem Mol Biol. 2016;164:120–126.
  • Spanaus K, von Eckardstein A. Evaluation of two fully automated immunoassay based tests for the measurement of 1α,25-dihydroxyvitamin D in human serum and comparison with LC-MS/MS. Clin Chem Lab Med. 2017;55(9):1305–1314.
  • Zittermann A, Ernst JB, Becker T, et al. Measurement of circulating 1,25-Dihydroxyvitamin D: comparison of an automated method with a liquid chromatography tandem mass spectrometry method. Int J Anal Chem. 2016;2016:8501435.
  • Vanderschueren D, Pye SR, O'Neill TW, et al. Active vitamin D (1,25-dihydroxyvitamin D) and bone health in Middle-aged and elderly men: the european male aging study (EMAS). J Clin Endocrinol Metab. 2013;98(3):995–1005.
  • Biancuzzo RM, Clarke N, Reitz RE, et al. Serum concentrations of 1,25-dihydroxyvitamin D2 and 1,25-dihydroxyvitamin D3 in response to vitamin D2 and vitamin D3 supplementation. J Clin Endocrinol Metab. 2013;98(3):973–979.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.